Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 8;21(1):37.
doi: 10.3390/e21010037.

Drug-Drug Interaction Extraction via Recurrent Hybrid Convolutional Neural Networks with an Improved Focal Loss

Affiliations

Drug-Drug Interaction Extraction via Recurrent Hybrid Convolutional Neural Networks with an Improved Focal Loss

Xia Sun et al. Entropy (Basel). .

Abstract

Drug-drug interactions (DDIs) may bring huge health risks and dangerous effects to a patient's body when taking two or more drugs at the same time or within a certain period of time. Therefore, the automatic extraction of unknown DDIs has great potential for the development of pharmaceutical agents and the safety of drug use. In this article, we propose a novel recurrent hybrid convolutional neural network (RHCNN) for DDI extraction from biomedical literature. In the embedding layer, the texts mentioning two entities are represented as a sequence of semantic embeddings and position embeddings. In particular, the complete semantic embedding is obtained by the information fusion between a word embedding and its contextual information which is learnt by recurrent structure. After that, the hybrid convolutional neural network is employed to learn the sentence-level features which consist of the local context features from consecutive words and the dependency features between separated words for DDI extraction. Lastly but most significantly, in order to make up for the defects of the traditional cross-entropy loss function when dealing with class imbalanced data, we apply an improved focal loss function to mitigate against this problem when using the DDIExtraction 2013 dataset. In our experiments, we achieve DDI automatic extraction with a micro F-score of 75.48% on the DDIExtraction 2013 dataset, outperforming the state-of-the-art approach by 2.49%.

Keywords: convolutional neural network; cross-entropy; dilated convolutions; drug-drug interaction; focal loss; relation extraction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The architecture of recurrent hybrid convolutional neural network model. This figure is an example of the sentence after drug blinding “DRUG1 modifies DRUG2 metabolism with increased serum levels of DRUG0.” (DDIExtraction 2013 dataset, file Acetazolamide-ddi.xml, sentence DDI-DrugBank.d368.s0).
Figure 2
Figure 2
The bidirectional recurrent structure used for obtaining the actual semantic embedding of each word. This figure is a partial example of the sentence “DRUG1 modifies DRUG2 metabolism with increased serum levels of DRUG0.” (DDIExtraction 2013 dataset, file Acetazolamide-ddi.xml, sentence DDI-DrugBank.d368.s0).

References

    1. Magro L., Moretti U., Leone R. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. Expert Opin. Drug Saf. 2012;11:83–94. doi: 10.1517/14740338.2012.631910. - DOI - PubMed
    1. Wishart D.S., Feunang Y.D., Guo A.C., Lo E.J., Marcu A., Grant J.R., Sajed T., Johnson D., Li C., Sayeeda Z., et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2017;46:D1074–D1082. doi: 10.1093/nar/gkx1037. - DOI - PMC - PubMed
    1. Thorn C.F., Klein T.E., Altman R.B. Pharmacogenomics. Springer; Berlin, Germany: 2013. PharmGKB: The pharmacogenomics knowledge base; pp. 311–320. - PMC - PubMed
    1. Hachad H., Ragueneau-Majlessi I., Levy R.H. A useful tool for drug interaction evaluation: The University of Washington Metabolism and Transport Drug Interaction Database. Hum. Genom. 2010;5:61–72. doi: 10.1186/1479-7364-5-1-61. - DOI - PMC - PubMed
    1. Baxter K., Preston C. Stockley’s Drug Interactions. Volume 495 Pharmaceutical Press; London, UK: 2010.

LinkOut - more resources